Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.01−0.02 (-1.94%)
Close on Nov 17, 2026Market cap $176.01MP/E –Yield –
Palisade Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Palisade Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$18.19M. For fiscal 2025 it was -$10.85M. The highest annual figure on record is -$4.77M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.85M | – |
| FY2024 | Dec 31, 2024 | -$12.19M | – |
| FY2023 | Dec 31, 2023 | -$11.13M | – |
| FY2022 | Dec 31, 2022 | -$13.36M | – |
| FY2021 | Dec 31, 2021 | -$14.77M | – |
| FY2020 | Dec 31, 2020 | -$4.77M | – |
| FY2019 | Dec 31, 2019 | -$7.26M | – |
| FY2018 | Dec 31, 2018 | -$7.69M | – |
| FY2017 | Dec 31, 2017 | -$13.42M | – |
| FY2016 | Dec 31, 2016 | -$15.62M | – |
| FY2015 | Dec 31, 2015 | -$18.93M | – |
| FY2014 | Dec 31, 2014 | -$11.71M | – |
| FY2013 | Dec 31, 2013 | -$10.59M | – |
| FY2012 | Dec 31, 2012 | -$8.48M | – |
| FY2011 | Dec 31, 2011 | -$8.10M | – |
| FY2010 | Dec 31, 2010 | -$9.98M | – |
| FY2009 | Dec 31, 2009 | -$5.14M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.60M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.89M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.14M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.82M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.33M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.38M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.13M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.18M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.75M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.66M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.20M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.53M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.04M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.25M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.06M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.75M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.72M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.25M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$869.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$673.37K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.68M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.05M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.90M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.64M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.66M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.66M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.52M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.85M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.29M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.32M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.37M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.44M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.08M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.48M | – |
See a number that looks wrong?